113 related articles for article (PubMed ID: 28391726)
1. Determinants of percent mammographic density in women with premature ovarian insufficiency.
Torelli FR; Brancalion MF; Yela DA; Benetti-Pinto CL
Climacteric; 2017 Jun; 20(3):280-284. PubMed ID: 28391726
[TBL] [Abstract][Full Text] [Related]
2. Mammographic breast density in women with premature ovarian failure: a prospective analysis.
Benetti-Pinto CL; Brancalion MF; Assis LH; Tinois E; Giraldo HP; Cabello C; Yela DA
Menopause; 2014 Sep; 21(9):933-7. PubMed ID: 24518154
[TBL] [Abstract][Full Text] [Related]
3. Mammographic density, response to hormones, and breast cancer risk.
Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
[TBL] [Abstract][Full Text] [Related]
4. Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis.
Hack CC; Emons J; Jud SM; Heusinger K; Adler W; Gass P; Haeberle L; Heindl F; Hein A; Schulz-Wendtland R; Uder M; Hartmann A; Beckmann MW; Fasching PA; Pöhls UG
Breast Cancer Res Treat; 2017 Dec; 166(3):701-708. PubMed ID: 28828694
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Stress Urinary Incontinence in Women with Premature Ovarian Insufficiency.
Tan R; Pu D; Cao J; Ge H; Chang X; Ye G; Wu J
J Womens Health (Larchmt); 2018 Dec; 27(12):1508-1512. PubMed ID: 30484729
[No Abstract] [Full Text] [Related]
6. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
7. Standard hormone therapy is inadequate for bone density in premature ovarian insufficiency.
Giraldo H; Benetti-Pinto C; Ferreira V; Garmes H; Yela D; Giraldo P
Gynecol Endocrinol; 2017 Apr; 33(4):283-286. PubMed ID: 27910707
[TBL] [Abstract][Full Text] [Related]
8. Hormone therapy use and mammographic density in postmenopausal Norwegian women.
Couto E; Qureshi SA; Hofvind S; Hilsen M; Aase H; Skaane P; Vatten L; Ursin G
Breast Cancer Res Treat; 2012 Feb; 132(1):297-305. PubMed ID: 22052325
[TBL] [Abstract][Full Text] [Related]
9. Premature ovarian insufficiency and perinatal parameters: A retrospective case-control study.
Sadrzadeh S; Painter RC; van Kasteren YM; Braat DD; Lambalk CB
Maturitas; 2017 Feb; 96():72-76. PubMed ID: 28041598
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI).
Szlendak-Sauer K; Jakubik D; Kunicki M; Skórska J; Smolarczyk R
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():61-5. PubMed ID: 27240263
[TBL] [Abstract][Full Text] [Related]
11. Circulating lipids, mammographic density, and risk of breast cancer in the Nurses' Health Study and Nurses' Health Study II.
Lucht SA; Eliassen AH; Bertrand KA; Ahern TP; Borgquist S; Rosner B; Hankinson SE; Tamimi RM
Cancer Causes Control; 2019 Sep; 30(9):943-953. PubMed ID: 31264139
[TBL] [Abstract][Full Text] [Related]
12. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
Stuedal A; Ma H; Bjørndal H; Ursin G
Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
[TBL] [Abstract][Full Text] [Related]
14. Breast density in women with premature ovarian failure or postmenopausal women using hormone therapy: analytical cross-sectional study.
Soares PM; Cabello C; Magna LA; Tinois E; Benetti-Pinto CL
Sao Paulo Med J; 2010 Jul; 128(4):211-4. PubMed ID: 21120432
[TBL] [Abstract][Full Text] [Related]
15. Sleep quality and fatigue in women with premature ovarian insufficiency receiving hormone therapy: a comparative study.
Benetti-Pinto CL; Menezes C; Yela DA; Cardoso TM
Menopause; 2019 Oct; 26(10):1141-1145. PubMed ID: 31290760
[TBL] [Abstract][Full Text] [Related]
16. Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasound.
Häberle L; Hack CC; Heusinger K; Wagner F; Jud SM; Uder M; Beckmann MW; Schulz-Wendtland R; Wittenberg T; Fasching PA
Eur J Med Res; 2017 Aug; 22(1):30. PubMed ID: 28854966
[TBL] [Abstract][Full Text] [Related]
17. Relationship between mean platelet volume and low-grade systemic coagulation with vitamin D deficiency in primary ovarian insufficiency.
Kebapcilar AG; Kulaksizoglu M; Ipekci SH; Korkmaz H; Kebapcilar L; Akyurek F; Taner CE; Gonen MS
Arch Gynecol Obstet; 2013 Jul; 288(1):207-12. PubMed ID: 23377179
[TBL] [Abstract][Full Text] [Related]
18. Mammographic densities during the menopausal transition: a longitudinal study of Australian-born women.
Guthrie JR; Milne RL; Hopper JL; Cawson J; Dennerstein L; Burger HG
Menopause; 2007; 14(2):208-15. PubMed ID: 17091098
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in transforming growth factor beta 1 and mammographic density in Singapore Chinese women.
Lee E; Van Den Berg D; Hsu C; Ursin G; Koh WP; Yuan JM; Stram DO; Yu MC; Wu AH
Cancer Res; 2013 Mar; 73(6):1876-82. PubMed ID: 23333936
[TBL] [Abstract][Full Text] [Related]
20. Changes and tracking of mammographic density in relation to Pike's model of breast tissue aging: a UK longitudinal study.
McCormack VA; Perry NM; Vinnicombe SJ; Dos Santos Silva I
Int J Cancer; 2010 Jul; 127(2):452-61. PubMed ID: 19924817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
